Small animal PET/CT series（Super Nova®）independently researched and developed by PINGSENG have obtained CE certification Promulgated by SGS authority of Switzerland.
Emerging markets (such as China and India) are offering high growth opportunities for market players operating in the pre-clinical imaging industry.
PINGSENG is a high-tech enterprise specialized in advanced molecular imaging devices. Its product portfolio spans pre-clinical, clinical, optical and veterinary imaging. The business has its wholly-owned R&D, Production, Sales and Services.
Building a long-term strategic partnership with customers, and combining the hospital scientific research strength with industrial engineering capability.